PeDRA 2025Abstract 084
Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline
36-Week Outcomes From BRAVE-AA Trials
Passeron T, Arkin L, Ohyama M, Vleugels RA, Senna M, Dutronc Y, Das T, Sontag A, Somani N, Craiglow B
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: HairPediatric dermatology
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00617-2 · Not in PubMed: details from Crossref